Oscar Health, Inc. (OSCR) Stock Analysis
Healthcare · Healthcare Plans · NYSE
Oscar Health, Inc. (OSCR) posted $11.70B in revenue for fiscal 2025 (up 27.5% year over year), with a net loss of $443.15M, and has compounded revenue about 90.8%/yr over five years, per its SEC filings.
Data last refreshed August 2, 2026 from SEC filings · how we compute this
The analyst's take on Oscar Health, Inc.
Oscar Health, Inc. has grown revenue from $488.19M to $11.70B over the last 7 fiscal years, compounding about 90.8% a year. The most recent year was up 27.5%, so growth has cooled from its longer-run pace.
Net margin sits at -3.8%, down 4.1 points year over year. It carries about $430.10M of total debt.
At today's valuation the market is pricing in roughly -5% annual free-cash-flow growth — versus the 38.4% it actually delivered over the last five years, so the price is arguably undemanding against what it has already proven. The one thing worth a second look in the filings is share count rising (dilution).
Synthesised from Oscar Health, Inc.'s SEC filings — descriptive, not advice. Ask the analyst your own question →
Oscar Health, Inc. revenue & earnings — last 7 fiscal years
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $488.19M | $462.80M | $1.84B | $4.13B | $5.86B | $9.18B | $11.70B |
| Gross profit | — | — | — | — | — | — | — |
| Net income | $-261.18M | $-406.82M | $-572.61M | $-606.27M | $-270.73M | $25.43M | $-443.15M |
| Net margin | -53.5% | -87.9% | -31.1% | -14.7% | -4.6% | 0.3% | -3.8% |
Source: Oscar Health, Inc. SEC filings (10-K).
Oscar Health, Inc.: 2 potential red flags in the filings
Patterns in the filed statements worth a second look — computed and cited, not AI guesswork, and not a signal to sell. The kind of thing that hides in a 10-K.
- Share count rising (dilution)Shares outstanding grew 37.6% over 3 years (216.3M → 297.7M) — existing holders' stakes are being diluted.
- Currently unprofitableThe latest fiscal year was a net loss (net margin -3.8%).
What growth is priced into OSCR stock?
At today's market cap of $8.47B, Oscar Health, Inc. is priced for free-cash-flow growth of about -5% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.06B from the FY ending 2025-12-31). For comparison, free cash flow actually grew 38.4%/yr over the last five fiscal years and revenue 90.8%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 7 years of Oscar Health, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track OSCR in your portfolio →
Oscar Health, Inc. financial history by metric
About Oscar Health, Inc.
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Oscar Health, Inc. — frequently asked questions
What is Oscar Health, Inc.'s revenue?
Oscar Health, Inc. (OSCR) reported revenue of $11.70B for fiscal year 2025, up 27.5% from the prior year, according to its SEC filings.
Is Oscar Health, Inc. profitable?
No — OSCR reported a net loss of $-443.15M in fiscal 2025.
What is OSCR's P/E ratio?
Oscar Health, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How fast is Oscar Health, Inc. growing?
OSCR's revenue grew at roughly 90.8% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Oscar Health, Inc. have?
As of fiscal year 2025, OSCR carried roughly $430.10M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Oscar Health, Inc.'s market cap?
Oscar Health, Inc. (OSCR) has a market capitalization of about $8.47B, based on the latest data in our nightly-refreshed cache.
When does Oscar Health, Inc.'s fiscal year end?
OSCR's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into OSCR stock?
At today's market cap of $8.47B, Oscar Health, Inc. is priced for free-cash-flow growth of about -5% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.06B from the FY ending 2025-12-31). For comparison, free cash flow actually grew 38.4%/yr over the last five fiscal years and revenue 90.8%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Oscar Health, Inc.'s official SEC filings (10-K and 10-Q), covering 7 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.